Announced positive interim data for DURAVYU 2.7mg in DME demonstrating meaningful, early and sustained visual acuity gains, strong anatomical ...

Topline data from pivotal Phase 3 TANDEM trial now expected in 4Q 2024 due to faster than expected enrollment –– On-track to report topline ...

Pacs Group said it is conducting an internal audit and cooperating with a government investigation into its referral and ...

Richard DiIorio, Chief Executive Officer of InfuSystem, said, "Our third quarter financial results reflect the forecasted acceleration in our business in the second half of the year. We saw ...

Vikki Velasquez is a researcher and writer who has managed, coordinated, and directed various community and nonprofit organizations. She has conducted in-depth research on social and economic ...

Financially stable C4 Therapeutics (CCCC) is worth watching for patient investors, but current lack of definitive data poses ...

Enter the Patient Engagement and Equity Report (PEER), developed by Lumanity, Red Thred Solutions, and Patient Alliances to create a bridge between the two sectors, and share information that ...

PACS Group stock has dropped nearly 33% since Monday following a scathing report from a forensic financial firm that accused ...

CAMBRIDGE, Mass., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM; “Cullinan”), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, ...

Clover Health's pivot to profitability over growth has led to significant earnings improvements. See why I rate CLOV stock as ...

When you buy through our links, Business Insider may earn an affiliate commission. Learn more The best sheets can make your bed a cozy, dreamy oasis that you look forward to falling into each ...

(NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, today announced financial ...